MedPath

Ablynx NV

Ablynx NV logo
🇧🇪Belgium
Ownership
Subsidiary
Established
2001-01-01
Employees
438
Market Cap
-
Website
http://www.ablynx.com

Clinical Trials

70

Active:65
Completed:4

Trial Phases

2 Phases

Phase 1:57
Phase 3:2

Drug Approvals

2

EMA:1
SFDA:1

Drug Approvals

Cablivi

Authorization Status
Authorised
Approval Date
Aug 30, 2018
EMA

Clinical Trials

Distribution across different clinical trial phases (59 trials with phase data)• Click on a phase to view related trials

Phase 1
57 (96.6%)
Phase 3
2 (3.4%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.